论文信息 - Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary - 字舞流文

Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary

Dhananjay D. Marathe | R. Pazdur | Todd R. Palmby | R. Justice | R. Sridhara | A. Ibrahim | J. Leighton | N. Mehrotra | Qi Liu | Haw-Jyh Chiu | W. Pierce | Debasis Ghosh | Shenghui Tang | V. E. Maher | J. F. Zirkelbach | Y. Ning | Stella Karuri | Chris Cottrell